Long-term outcome of treatment for ann arbor Stage 1 Hodgkin's disease: Patterns of failure, late toxicity and second malignancies
- 1 October 1997
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 39 (3), 609-616
- https://doi.org/10.1016/s0360-3016(97)00371-4
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionationRadiotherapy and Oncology, 1995
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995
- Second solid tumors and leukemia after treatment for Hodgkin's disease: An analysis of 1121 patients from a single institutionInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: Evidence of a more difficult rescue for patients relapsed after chemotherapyEuropean Journal Of Cancer, 1992
- Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.Journal of Clinical Oncology, 1992
- Coronary artery disease mortality in patients treated for hodgkin's diseaseCancer, 1992
- The EORTC trials for limited stage Hodgkin's diseaseEuropean Journal Of Cancer, 1992
- Pericarditis and myocardial infarctions after Hodgkin's disease therapyInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy.Journal of Clinical Oncology, 1987
- Clinical versus Pathologic Stage I and II Hodgkin’s DiseaseOncology, 1980